AngioDynamics, Inc.
ANGO
$13.59
$0.151.12%
NASDAQ
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 86.61M | 78.42M | 79.43M | 75.71M | 80.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 86.61M | 78.42M | 79.43M | 75.71M | 80.16M |
| Cost of Revenue | 39.83M | 36.94M | 34.65M | 33.85M | 37.94M |
| Gross Profit | 46.77M | 41.48M | 44.78M | 41.86M | 42.22M |
| SG&A Expenses | 41.53M | 38.31M | 37.00M | 40.78M | 36.76M |
| Depreciation & Amortization | 2.72M | 2.67M | 2.64M | 2.65M | 2.59M |
| Other Operating Expenses | 138.00K | -- | -- | -- | -493.00K |
| Total Operating Expenses | 92.26M | 84.85M | 81.92M | 83.61M | 83.30M |
| Operating Income | -5.65M | -6.43M | -2.49M | -7.90M | -3.14M |
| Income Before Tax | -11.04M | -8.07M | -6.36M | -10.84M | -6.11M |
| Income Tax Expenses | 370.00K | 12.00K | -5.00K | 65.00K | -60.00K |
| Earnings from Continuing Operations | -11.41M | -8.08M | -6.35M | -10.90M | -6.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.41M | -8.08M | -6.35M | -10.90M | -6.05M |
| EBIT | -5.65M | -6.43M | -2.49M | -7.90M | -3.14M |
| EBITDA | -353.00K | -838.00K | 3.26M | -1.88M | -707.00K |
| EPS Basic | -0.27 | -0.19 | -0.15 | -0.26 | -0.15 |
| Normalized Basic EPS | -0.10 | -0.02 | -0.04 | -0.12 | -0.05 |
| EPS Diluted | -0.27 | -0.19 | -0.15 | -0.26 | -0.15 |
| Normalized Diluted EPS | -0.10 | -0.02 | -0.04 | -0.12 | -0.05 |
| Average Basic Shares Outstanding | 41.70M | 41.60M | 41.54M | 41.17M | 40.98M |
| Average Diluted Shares Outstanding | 41.70M | 41.60M | 41.54M | 41.17M | 40.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |